Content
05/29/2024
Brooklyn, NY USA
Matter Bio
completed $7 million Seed Round funding. Investors include
LifeSpan Vision Ventures (lead), quadraScope Ventures.
About
Matter Bio is a longevity holding company focused on preserving genome integrity
As we age, our genome is constantly being damaged by exogenous and endogenous sources.
Occasionally errors are missed and incorporated into the DNA in the form of mutations, structural variations, epigenetic drift, and other types of information loss.
At Matter, we have assembled a world-class team of scientists and executives to help counter this critical information loss in the genome.
To achieve this, we are focusing on a number of assets that address key stages in the genomic information loss continuum.
Startup
Sector:
Biotech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
